The US Congress expands requirements for pharmaceutical companies to file agreements with the FTC and DOJ
Year: 2018
Type: article
Source: e-Competitions Bulletin
Authors: Krista Hessler Carver, Andrew D. Lazerow, Michael P. Stern, K Ramachandran Pillai
Institution: Covington and Burling
Language: English
Subfield: Economics and Econometrics
Domain: Social Sciences
Open Access status: closed
OpenAlex ID: W3192609869